Showing results (321-330 of 338) with videos related to
Sort By:
Pageof 34
Cancer Research|November 9, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Emily A Egusa, Sinan Wang, et al.European Urology|April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate CancerWilliam S Chen, Rahul Aggarwal, Li Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective StudyRahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.Nature Medicine|August 15, 2017
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4Xiangpeng Dai, Wenjian Gan, Xiaoning Li, et al.Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.Cell Reports. Medicine|January 20, 2024
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomasShiqin Liu, Timothy Chai, Fernando Garcia-Marques, et al.Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.Neurosurgery|August 11, 2016
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle StudyAdam M Sonabend, Brad E Zacharia, Michael B Cloney, et al.The New England Journal of Medicine|September 16, 2024
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial CarcinomaAndrea B Apolo, Karla V Ballman, Guru Sonpavde, et al.Pageof 34